Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
第一作者:
D V,Skarlos
第一单位:
Agii Anargiri Cancer Hospital, Athens, Greece.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);曲线下面积(Area Under Curve);卡铂(Carboplatin);死亡原因(Cause of Death);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);疾病恶化(Disease Progression);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);希腊(Greece);人类(Humans);输注, 静脉内(Infusions, Intravenous);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);肿瘤, 残余(Neoplasm, Residual);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);中性粒细胞减少(Neutropenia);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);缓解诱导(Remission Induction);存活率(Survival Rate);血小板减少(Thrombocytopenia)
PMID
9346224
发布时间
2015-11-19
- 浏览13

Seminars in oncology
S15-57-S15-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文